Updated just now · Live
Stock analysis, price data, and AI-powered insights for Celularity Inc (CELU).
Celularity Inc operates in the Biotechnology sector. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for CELU.
How to read insider trading filings
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). CELU Stock Intelligence Report. [stoxpulse.com/stocks/celu]
Disclaimer: The information on this page about Celularity Inc (CELU) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Celularity Inc.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
No price data available.
No earnings data available.
Nexgel new strategic partner, Sequence LifeScience...
9h ago
Celularity Announces Closing of Transaction with N...
11h ago
StoxPulse AI results for CELU: Pulse Score 60/100. Primary sentiment trends from 4 news sources and 20 SEC filings indicate a bullish outlook.
Market Cap
$35.8M
P/E Ratio
—
EPS
$-0.88
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Nexgel new strategic partner, Sequence LifeScience, leads financing with $5.5 million to complete acquisition of Celularity degenerative disease segment
Celularity Announces Closing of Transaction with NexGel
Celularity announces receipt of Nasdaq notice regarding late form 10-K filing
Celularity Receives Nasdaq Notice Regarding Late Form 10-K Filing